PRAA vs TRST

PRAA presents a stark contrast between deep value metrics and severe fundamental deterioration, highlighted by a critical Piotroski F-Score of 1/9. While the stock trades at a discount to book value (P/B 0.83) and shows strong recent price momentum (+55.9% in 6 months), the underlying financial health is weak with a high Debt/Equity ratio of 3.60. The company is experiencing extreme earnings volatility, evidenced by a massive -2893.8% surprise in late 2025, though recent quarterly growth suggests a potential turnaround. Overall, the valuation is attractive, but the deterministic health scores signal high risk.

TRST presents a stark contrast between deep fundamental value and deteriorating operational health, highlighted by a weak Piotroski F-Score of 3/9. While the stock is significantly undervalued relative to its Graham Number ($52.77) and Intrinsic Value ($95.88), the low health score and a very bearish technical trend (10/100) suggest significant headwinds. Strong earnings growth (41.7% YoY) and a low PEG ratio (0.63) provide a bullish growth narrative, but these are offset by poor insider sentiment and operational red flags.